Skip to main content
Fig. 8 | Future Journal of Pharmaceutical Sciences

Fig. 8

From: Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma

Fig. 8

a RT-PCR analysis conducted with a cytosolic fraction of caspase 3 and p53 activation G3PDH was used as an internal control for normalization of equal loading. b Western blot analysis of caspase 3, p53, and cytochrome c from whole protein extracted from the liver of the control, DEN+CCl4-induced, and post-treatment with harmalol of HCC-induced mice. Tubuline was used as loading control. Bar graphs represent the quantification of each marker

Back to article page